Complementation in hybrid cells derived from mutagen-induced mouse clones deficient in hypoxanthine-guanine phosphoribosyl-transferase activity.
D000230:Adenocarcinoma; D000476:Alkanesulfonates; D000818:Animals; D001345:Autoradiography; D001375:Azaguanine / Q000494:pharmacology; D002250:Carbon Radioisotopes; D002460:Cell Line; D002474:Cell-Free System; D002999:Clone Cells / Q000187:drug effects / Q000201:enzymology; D004351:Drug Resistance; D005796:Genes; D005816:Genetic Complementation Test; D006822:Hybrid Cells / Q000201:enzymology*; D007042:Hypoxanthines / Q000378:metabolism; D051379:Mice; D008809:Mice, Inbred C3H; D009153:Mutagens; D009154:Mutation; D009604:Nitrosoguanidines; D010430:Pentosyltransferases / Q000096:biosynthesis* / Q000378:metabolism; D013866:Thioguanine / Q000494:pharmacology
D000476:Alkanesulfonates; D002250:Carbon Radioisotopes; D007042:Hypoxanthines; D009153:Mutagens; D009604:Nitrosoguanidines; D010430:Pentosyltransferases; D013866:Thioguanine; D001375:Azaguanine